Lm. Han et al., PROTEIN-BINDING AND SIGNALING PROPERTIES OF RIN1 SUGGEST A UNIQUE EFFECTOR FUNCTION, Proceedings of the National Academy of Sciences of the United Statesof America, 94(10), 1997, pp. 4954-4959
wHuman RIN1 was first characterized as a RAS binding protein based on
the properties of its carboxyl-terminal domain, We now show that full-
length RIN1 interacts with activated RAS in mammalian cells and define
s a minimum region of 434 aa required for efficient RAS binding, RIN1
interacts with the ''effector domain'' of RAS and employs some RAS det
erminants that are common to, and others that are distinct from, those
required for the binding of RAF1, a known RAS effector, The same doma
in of RIN1 that binds RAS also interacts with 14-3-3 proteins, extendi
ng the similarity between RIN1 and other RAS effecters, When expressed
in mammalian cells, the RAS binding domain of RIN1 can act as a domin
ant negative signal transduction blocker, The amino-terminal domain of
RIN1 contains a proline-rich sequence similar to consensus Src homolo
gy 3 (SH3) binding regions, This RIN1 sequence shows preferential bind
ing to the ABL-SH3 domain in vitro. Moreover, the amino-terminal domai
n of RIN1 directly associates with, and is tyrosine phosphorylated by,
c-ABL, In addition, RIN1 encodes a functional SH2 domain that has the
potential to activate downstream signals, These data suggest that RIN
1 is able to mediate multiple signals, A differential pattern of expre
ssion and alternate splicing indicate several levels of RIN1 regulatio
n.